Takeda Pharmaceutical Company Limited
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$16.1M
22 notices · 967,266 sh
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-10Lauren Rusckowski Duprey, Chief Transformation Officer$634,408
2026-09-02Plump Andrew Stewart, President, R&D$2,148,372
2026-08-19Plump Andrew Stewart, President, R&D$363,348
2026-08-14Nicola Greenway, Chief Human Resources Officer$225,722
2026-08-11Elaine Shannon, Global Quality Officer$355,334
2026-08-07Nicola Greenway, Chief Human Resources Officer$578,562
2026-07-13Marcello Pignagnoli Agosti, Head, Strat. & Port. Dev.$416,850
2026-07-13Lauren Rusckowski Duprey, Chief Transformation Officer$863,947
2026-07-13Giles Platford, President, IBU$564,406
2026-07-13Natalie Furney, Global General Counsel$560,351
2026-07-13Gabriele Ricci, Chief Data & Tech. Officer$455,545
2026-07-13Nicola Greenway, Chief Human Resources Officer$123,072
2026-07-13Elaine Shannon, Global Quality Officer$72,351
2026-07-13Ramy Riad, President, PDT BU$132,149
2026-07-13Awny Farajallah, Chief Medical Officer$254,399
2026-07-13Rhonda Pacheco, President, U.S. Business Unit$306,789
2026-07-13Andrew Plump, President, R&D$3,002,258
2026-07-13Teresa Bitetti, President, OBU$908,019
2026-07-13Julie Kim, CEO - Elect$1,617,344
2025-12-09Lauren Rusckowski Duprey, Chief Transformation Officer$421,182
2025-12-05Teresa Marie Bitetti, President, OBU$1,242,688
2025-12-04Giles Richard Platford, President, IBU$836,005